AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 39697201 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcutaneous injection of PEG-IFN-
Number of subjects: 54
Study 39697289 — intervention group
Group type: EXPERIMENTAL
Intervention: Workstation ergonomics modifications group (EMG)
Number of subjects: 96
Study 39697325 — intervention group
Group type: EXPERIMENTAL
Intervention: PH-762 (self-delivering RNAi)
Number of subjects: 0
Study 39697344 — intervention group
Group type: EXPERIMENTAL
Intervention: TLR8 agonism and anti-PD-1 blockade
Number of subjects: 0
Study 39697397 — intervention group
Group type: EXPERIMENTAL
Intervention: Medications for Opioid Use Disorder (MOUD)
Number of subjects: 36262
Study 39697396 — intervention group
Group type: EXPERIMENTAL
Intervention: Topiramate (TPM) adjunctive to quetiapine
Number of subjects: 75
Study 39697396 — intervention group
Group type: COMPARATOR
Intervention: Quetiapine plus placebo
Number of subjects: 75
Study 39697620 — intervention group
Group type: EXPERIMENTAL
Intervention: Palbociclib plus endocrine therapy (ET)
Number of subjects: 209
Study 39697620 — intervention group
Group type: EXPERIMENTAL
Intervention: Abemaciclib plus endocrine therapy (ET)
Number of subjects: 209
Study 39697620 — intervention group
Group type: EXPERIMENTAL
Intervention: Dalpiciclib plus endocrine therapy (ET)
Number of subjects: 209
Study 39697785 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemo-mechanical caries removal (CMCR) with Papacarie®
Number of subjects: 0
Study 39697785 — intervention group
Group type: COMPARATOR
Intervention: Conventional drilling
Number of subjects: 0
Study 39697785 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemo-mechanical caries removal (CMCR)
Number of subjects: 0
Study 39697813 — intervention group
Group type: EXPERIMENTAL
Intervention: Text message reminder intervention for self-management of oral anticancer medication
Number of subjects: 43
Study 39697813 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified in detail)
Number of subjects: 43
Study 39697819 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindful Awareness in Body-oriented Therapy (MABT) as an adjunct to medication for opioid use disorder (MOUD)
Number of subjects: 0
Study 39697819 — intervention group
Group type: COMPARATOR
Intervention: Medication for opioid use disorder (MOUD) only
Number of subjects: 0
Study 39697865 — intervention group
Group type: EXPERIMENTAL
Intervention: Dapagliflozin for 3 months
Number of subjects: 50
Study 39697865 — intervention group
Group type: COMPARATOR
Intervention: Insulin degludec for 3 months
Number of subjects: 50
Study 39698035 — intervention group
Group type: EXPERIMENTAL
Intervention: Serum 25-hydroxy vitamin D level
Number of subjects: 1513
Study 39698150 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 L/min supplemental oxygen (high-dose oxygen therapy)
Number of subjects: 0
Study 39698150 — intervention group
Group type: COMPARATOR
Intervention: Placebo (control)
Number of subjects: 0
Study 39698346 — intervention group
Group type: EXPERIMENTAL
Intervention: SGLT2 inhibitors (SGLT2i)
Number of subjects: 112
Study 39698346 — intervention group
Group type: EXPERIMENTAL
Intervention: Additive to renin-angiotensin system inhibition (RASi)
Number of subjects: 112
Study 39698744 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulsed field ablation (PFA) using TactiCath SE, StablePoint, and ThermoCool ST catheters
Number of subjects: 82
Study 39698744 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulsed field ablation (PFA)
Number of subjects: 82
Study 39698861 — intervention group
Group type: EXPERIMENTAL
Intervention: High PEEP
Number of subjects: 3774
Study 39698942 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-steroidal anti-inflammatory drugs (NSAIDs)
Number of subjects: 1646
Study 39698942 — intervention group
Group type: COMPARATOR
Intervention: Antibiotics
Number of subjects: 1646
Study 39699174 — intervention group
Group type: EXPERIMENTAL
Intervention: Cycled light (CL)
Number of subjects: 1633
Study 39699245 — intervention group
Group type: EXPERIMENTAL
Intervention: Remdesivir
Number of subjects: 244
Study 39699245 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 244
Study 39699595 — intervention group
Group type: EXPERIMENTAL
Intervention: Maternal thiamine supplementation (0, 1.2, 2.4, or 10 mg daily)
Number of subjects: 335
Study 39699832 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with peripheral arterial disease (PAD)
Number of subjects: 313
Study 39699832 — intervention group
Group type: COMPARATOR
Intervention: Patients without peripheral arterial disease (PAD)
Number of subjects: 313
Study 39699832 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with PAD
Number of subjects: 313
Study 39699832 — intervention group
Group type: COMPARATOR
Intervention: Patients without PAD
Number of subjects: 313
Study 39699848 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin icodec with dosing guide app
Number of subjects: 0
Study 39699848 — intervention group
Group type: COMPARATOR
Intervention: Insulin glargine U300
Number of subjects: 0
Study 39699863 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic liver resection (LLR)
Number of subjects: 289
Study 39699863 — intervention group
Group type: COMPARATOR
Intervention: Microwave ablation (MWA)
Number of subjects: 289
Study 39699886 — intervention group
Group type: EXPERIMENTAL
Intervention: Lenadogene nolparvovec
Number of subjects: 76
Study 39699886 — intervention group
Group type: COMPARATOR
Intervention: Sham injection
Number of subjects: 76
Study 39699896 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief outpatient rehabilitation program based on a cognitive and behavioral approach
Number of subjects: 314
Study 39699896 — intervention group
Group type: COMPARATOR
Intervention: Care as usual
Number of subjects: 314
Study 39699905 — intervention group
Group type: EXPERIMENTAL
Intervention: SBRT followed by sorafenib
Number of subjects: 177
Study 39699905 — intervention group
Group type: COMPARATOR
Intervention: Sorafenib
Number of subjects: 177
Study 39700058 — intervention group
Group type: EXPERIMENTAL
Intervention: 14Fr Thal CT (14CT)
Number of subjects: 109
Study 39700058 — intervention group
Group type: COMPARATOR
Intervention: 28Fr CT (28CT)
Number of subjects: 109
Study 39700066 — intervention group
Group type: EXPERIMENTAL
Intervention: Voice-based algorithm
Number of subjects: 607
Study 39700066 — intervention group
Group type: EXPERIMENTAL
Intervention: Voice-based algorithm in females aged 60 years or older
Number of subjects: 607
Study 39700066 — intervention group
Group type: EXPERIMENTAL
Intervention: Voice-based algorithm in individuals with hypertension
Number of subjects: 607
Study 39700066 — intervention group
Group type: COMPARATOR
Intervention: Voice-based algorithm compared to ADA risk score
Number of subjects: 607
Study 39700102 — intervention group
Group type: EXPERIMENTAL
Intervention: INTERACT3 Care Bundle including protocols for management of physiological variables such as systolic blood pressure (SBP) reduction (target <140mmHg), glucose control (target 6.1-7.8 mmol/L for non-diabetics and 7.8-10.0 mmol/L for diabetics), anti-pyrexia treatment (target body temperature ≤37.5°C), and rapid reversal of warfarin-related anticoagulation (target INR <1.5).
Number of subjects: 78
Study 39700102 — intervention group
Group type: EXPERIMENTAL
Intervention: INTERACT3 Care Bundle
Number of subjects: 78
Study 39700313 — intervention group
Group type: EXPERIMENTAL
Intervention: Primary HPV-based screening
Number of subjects: 14719
Study 39700313 — intervention group
Group type: COMPARATOR
Intervention: Primary cytology-based screening
Number of subjects: 14719
Study 39700448 — intervention group
Group type: EXPERIMENTAL
Intervention: Early initiation of direct oral anticoagulants (DOACs) within 48 hours for minor and moderate stroke, 6-7 days for major stroke.
Number of subjects: 1694
Study 39700448 — intervention group
Group type: COMPARATOR
Intervention: Late initiation of direct oral anticoagulants (DOACs) after 48 hours for minor, 3-4 days for moderate, 12-14 days for major stroke.
Number of subjects: 1694
Study 39700497 — intervention group
Group type: EXPERIMENTAL
Intervention: Synchronous lifestyle intervention via videoconference group sessions
Number of subjects: 328
Study 39700497 — intervention group
Group type: COMPARATOR
Intervention: Asynchronous lifestyle intervention via private Facebook groups
Number of subjects: 328
Study 39700502 — intervention group
Group type: EXPERIMENTAL
Intervention: Danicopan (150 mg 3 times daily)
Number of subjects: 86
Study 39700502 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 86
Study 39700514 — intervention group
Group type: EXPERIMENTAL
Intervention: Spanish-language advance care planning (ACP) interventions
Number of subjects: 16
Study 39700514 — intervention group
Group type: EXPERIMENTAL
Intervention: Bilingual research assistants (RAs) attending events
Number of subjects: 16
Study 39700681 — intervention group
Group type: EXPERIMENTAL
Intervention: Nivolumab (Nivo) as early switch maintenance after 1st-line chemotherapy, administered at a dose of 240 mg i.v. every 2 weeks until progressive disease, intolerable toxicity, or for a maximum of 2 years.
Number of subjects: 125
Study 39700681 — intervention group
Group type: COMPARATOR
Intervention: Best supportive care followed by delayed second-line Nivolumab at disease progression.
Number of subjects: 125
Study 39700681 — intervention group
Group type: COMPARATOR
Intervention: Comparison of early switch maintenance Nivolumab vs delayed second-line Nivolumab.
Number of subjects: 125
Study 39700737 — intervention group
Group type: EXPERIMENTAL
Intervention: Coach Pepper (n = 16)
Number of subjects: 32
Study 39700737 — intervention group
Group type: COMPARATOR
Intervention: Tablet-based multimodal training (n = 16)
Number of subjects: 32
Study 39701047 — intervention group
Group type: EXPERIMENTAL
Intervention: Tenapanor
Number of subjects: 641
Study 39701047 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 641
Study 39701097 — intervention group
Group type: EXPERIMENTAL
Intervention: Nivolumab with 5-fluorouracil/leucovorin (5FULV) and liposomal irinotecan
Number of subjects: 30
Study 39701119 — intervention group
Group type: EXPERIMENTAL
Intervention: artemether-lumefantrine
Number of subjects: 100
Study 39701119 — intervention group
Group type: EXPERIMENTAL
Intervention: artemether-lumefantrine-amodiaquine
Number of subjects: 100
Study 39701119 — intervention group
Group type: EXPERIMENTAL
Intervention: artemether-lumefantrine-amodiaquine plus primaquine
Number of subjects: 100
Study 39701119 — intervention group
Group type: EXPERIMENTAL
Intervention: artesunate-amodiaquine
Number of subjects: 100
Study 39701119 — intervention group
Group type: EXPERIMENTAL
Intervention: artesunate-amodiaquine plus primaquine
Number of subjects: 100
Study 39701119 — intervention group
Group type: COMPARATOR
Intervention: Control (no primaquine)
Number of subjects: 100
Study 39701488 — intervention group
Group type: EXPERIMENTAL
Intervention: DDDR (rate-adaptive atrial support)
Number of subjects: 26
Study 39701488 — intervention group
Group type: COMPARATOR
Intervention: VDD pacing
Number of subjects: 26
Study 39701488 — intervention group
Group type: EXPERIMENTAL
Intervention: Study period
Number of subjects: 26
Study 39701488 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline distance
Number of subjects: 26
Study 39701488 — intervention group
Group type: EXPERIMENTAL
Intervention: Echocardiographic parameters
Number of subjects: 26
Study 39701577 — intervention group
Group type: EXPERIMENTAL
Intervention: Storytelling Through Music (STM) intervention over 6 weeks
Number of subjects: 24
Study 39701577 — intervention group
Group type: COMPARATOR
Intervention: Control group (wait-list)
Number of subjects: 24
Study 39701583 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise intervention (home-based, digitally supervised, 3 times per week for 8 weeks) consisting of aerobic exercise on a cycle ergometer and resistance exercises tailored to patient health status.
Number of subjects: 30
Study 39701583 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control group (maintains normal daily activities, offered intervention within 6 months from ASCT).
Number of subjects: 30
Study 39701660 — intervention group
Group type: EXPERIMENTAL
Intervention: Mechanical ventilation (MV; invasive or non-invasive) for at least 14 consecutive days.
Number of subjects: 2773
Study 39701967 — intervention group
Group type: EXPERIMENTAL
Intervention: Penile revascularization surgery
Number of subjects: 35
Study 39702010 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcatheter aortic valve replacement (TAVR)
Number of subjects: 3
Study 39702010 — intervention group
Group type: COMPARATOR
Intervention: Pre-operative condition (before TAVR)
Number of subjects: 3
Study 39702029 — intervention group
Group type: EXPERIMENTAL
Intervention: Cryospray
Number of subjects: 130
Study 39702029 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 130
Study 39702045 — intervention group
Group type: EXPERIMENTAL
Intervention: HAZDPac treatment (Hydroxychloroquine paired with Azithromycin, Vitamin C, Vitamin D, and Zinc)
Number of subjects: 83
Study 39702045 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 83
Study 39702060 — intervention group
Group type: EXPERIMENTAL
Intervention: Cooled dialysate at 35 °C
Number of subjects: 43
Study 39702060 — intervention group
Group type: COMPARATOR
Intervention: Standard care (dialysate-temperature 36.5 °C)
Number of subjects: 43
Study 39702069 — intervention group
Group type: EXPERIMENTAL
Intervention: Rehabilitation program after knee surgery
Number of subjects: 62
Study 39702069 — intervention group
Group type: EXPERIMENTAL
Intervention: Rehabilitation program in rural context
Number of subjects: 62
Study 39702069 — intervention group
Group type: EXPERIMENTAL
Intervention: Rehabilitation program in urban context
Number of subjects: 62
Study 39702069 — intervention group
Group type: COMPARATOR
Intervention: Rehabilitation program in rural vs urban context
Number of subjects: 62
Study 39702081 — intervention group
Group type: EXPERIMENTAL
Intervention: Activation group
Number of subjects: 24
Study 39702081 — intervention group
Group type: EXPERIMENTAL
Intervention: Inspiratory muscle fatigue group
Number of subjects: 24
Study 39702102 — intervention group
Group type: EXPERIMENTAL
Intervention: High-intensity gait training initiated early (< 60 days post-SCI)
Number of subjects: 108
Study 39702102 — intervention group
Group type: EXPERIMENTAL
Intervention: High-intensity gait training initiated sub-acute (3 months post-SCI)
Number of subjects: 108
Study 39702102 — intervention group
Group type: EXPERIMENTAL
Intervention: High-intensity gait training initiated chronic (6 months post-SCI)
Number of subjects: 108
Study 39702102 — intervention group
Group type: COMPARATOR
Intervention: Standard of care (control group)
Number of subjects: 108
Study 39702102 — intervention group
Group type: EXPERIMENTAL
Intervention: Primary outcomes: gait speed (10 m Walk Test)
Number of subjects: 108
Study 39702102 — intervention group
Group type: EXPERIMENTAL
Intervention: Primary outcomes: walking endurance (6-Minute Walk Test)
Number of subjects: 108
Study 39702102 — intervention group
Group type: EXPERIMENTAL
Intervention: Secondary outcomes: daily step count via wearable sensors
Number of subjects: 108
Study 39702102 — intervention group
Group type: EXPERIMENTAL
Intervention: Secondary outcomes: lower extremity strength
Number of subjects: 108
Study 39702102 — intervention group
Group type: EXPERIMENTAL
Intervention: Secondary outcomes: quality of life measures
Number of subjects: 108
Study 39702118 — intervention group
Group type: EXPERIMENTAL
Intervention: Weekly piano practice (PP)
Number of subjects: 156
Study 39702118 — intervention group
Group type: COMPARATOR
Intervention: 'Music culture' (MC) sessions
Number of subjects: 156
Study 39702118 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (PP and MC)
Number of subjects: 156
Study 39702145 — intervention group
Group type: EXPERIMENTAL
Intervention: 15-minute episode intervention
Number of subjects: 440
Study 39702145 — intervention group
Group type: COMPARATOR
Intervention: 15-minute episode control
Number of subjects: 440
Study 39702145 — intervention group
Group type: EXPERIMENTAL
Intervention: 3-minute music video intervention
Number of subjects: 440
Study 39702145 — intervention group
Group type: COMPARATOR
Intervention: 3-minute music video control
Number of subjects: 440
Study 39702151 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous dexamethasone 10 mg (3 doses: pre-anesthesia, 24h, and 48h post-surgery)
Number of subjects: 48
Study 39702151 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous dexamethasone 10 mg
Number of subjects: 48
Study 39702162 — intervention group
Group type: EXPERIMENTAL
Intervention: Instrument-assisted soft tissue mobilization (IASTM) applied to the triceps surae muscle and plantar fascia on the non-dominant legs.
Number of subjects: 35
Study 39702162 — intervention group
Group type: COMPARATOR
Intervention: No intervention applied to the dominant legs (control group).
Number of subjects: 35
Study 39702178 — intervention group
Group type: EXPERIMENTAL
Intervention: Unilateral heel pain
Number of subjects: 200
Study 39702178 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower physical activity level
Number of subjects: 200
Study 39702178 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher number of repetitions in the clinical heel-rise test
Number of subjects: 200
Study 39702178 — intervention group
Group type: EXPERIMENTAL
Intervention: Shorter duration of heel pain
Number of subjects: 200
Study 39702178 — intervention group
Group type: EXPERIMENTAL
Intervention: Being married/cohabitating
Number of subjects: 200
Study 39702178 — intervention group
Group type: COMPARATOR
Intervention: Bilateral heel pain
Number of subjects: 200
Study 39702205 — intervention group
Group type: EXPERIMENTAL
Intervention: Robotic reaching task under high time constraint
Number of subjects: 14
Study 39702205 — intervention group
Group type: EXPERIMENTAL
Intervention: Robotic reaching task under low time constraint
Number of subjects: 14
Study 39702205 — intervention group
Group type: EXPERIMENTAL
Intervention: Robotic reaching task
Number of subjects: 14
Study 39702235 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-carbohydrate diet (LCD) for 6 weeks
Number of subjects: 14
Study 39702318 — intervention group
Group type: EXPERIMENTAL
Intervention: tofacitinib 5 mg BID (after switching from adalimumab)
Number of subjects: 180
Study 39702318 — intervention group
Group type: COMPARATOR
Intervention: continuing tofacitinib 5 mg BID
Number of subjects: 180
Study 39702318 — intervention group
Group type: EXPERIMENTAL
Intervention: tofacitinib 5 mg BID
Number of subjects: 180
Study 39702318 — intervention group
Group type: COMPARATOR
Intervention: adalimumab 40 mg every 2 weeks
Number of subjects: 180
Study 39702320 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole food, plant-based diet for 8 weeks
Number of subjects: 17
Study 39702343 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcutaneous electrical stimulation (TENS) during physiotherapy
Number of subjects: 109
Study 39702343 — intervention group
Group type: COMPARATOR
Intervention: Placebo treatment during physiotherapy
Number of subjects: 109
Study 39702343 — intervention group
Group type: COMPARATOR
Intervention: Control group (no TENS) during physiotherapy
Number of subjects: 109
Study 39702346 — intervention group
Group type: EXPERIMENTAL
Intervention: Powered finger exoskeleton (I-Phlex)
Number of subjects: 6
Study 39702395 — intervention group
Group type: EXPERIMENTAL
Intervention: HEV239 vaccine (two doses)
Number of subjects: 0
Study 39702395 — intervention group
Group type: EXPERIMENTAL
Intervention: HEV239 vaccine (single dose)
Number of subjects: 0
Study 39702402 — intervention group
Group type: EXPERIMENTAL
Intervention: Intra-articular injection of 1000 mg vancomycin suspended in 25 mL of normal saline after arthrotomy closure
Number of subjects: 100
Study 39702402 — intervention group
Group type: EXPERIMENTAL
Intervention: Intra-articular injection of 1000 mg vancomycin
Number of subjects: 100
Study 39702504 — intervention group
Group type: EXPERIMENTAL
Intervention: Process-based therapy (PBT)
Number of subjects: 80
Study 39702504 — intervention group
Group type: COMPARATOR
Intervention: Routine cognitive behavioral therapy (r-CBT)
Number of subjects: 80
Study 39702584 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiparametric magnetic resonance imaging (mpMRI)
Number of subjects: 82
Study 39702584 — intervention group
Group type: EXPERIMENTAL
Intervention: Prostate-specific membrane antigen positron emission tomography/computed tomography (PSMA PET/CT)
Number of subjects: 82
Study 39702673 — intervention group
Group type: EXPERIMENTAL
Intervention: Improved autonomous AI system for diabetic retinal disease identification using a handheld fundus camera (RetinaVue700).
Number of subjects: 626
Study 39702673 — intervention group
Group type: COMPARATOR
Intervention: Wisconsin Reading Center level I prognostic standard using widefield stereoscopic photography and macular Optical Coherence Tomography.
Number of subjects: 626
Study 39702684 — intervention group
Group type: EXPERIMENTAL
Intervention: TaTME
Number of subjects: 94
Study 39702769 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness-based intervention for psychosis (MBI-p)
Number of subjects: 152
Study 39702769 — intervention group
Group type: COMPARATOR
Intervention: Psychoeducation program
Number of subjects: 152
Study 39702896 — intervention group
Group type: EXPERIMENTAL
Intervention: AS03-adjuvanted H7N9 vaccine (1.9 μg, 3.75 μg, and 7.5 μg)
Number of subjects: 838
Study 39702896 — intervention group
Group type: EXPERIMENTAL
Intervention: AS03-adjuvanted H7N9 vaccine (various doses)
Number of subjects: 838
Study 39702896 — intervention group
Group type: EXPERIMENTAL
Intervention: AS03-adjuvanted H7N9 vaccine
Number of subjects: 838
Study 39702991 — intervention group
Group type: EXPERIMENTAL
Intervention: Tele-neuropsychological assessment via videoconference
Number of subjects: 100
Study 39702991 — intervention group
Group type: COMPARATOR
Intervention: Face-to-face neuropsychological assessment
Number of subjects: 100
Study 39702991 — intervention group
Group type: EXPERIMENTAL
Intervention: Satisfaction questionnaire after remote assessment
Number of subjects: 100
Study 39702994 — intervention group
Group type: EXPERIMENTAL
Intervention: Assisted pregnancies
Number of subjects: 630
Study 39702994 — intervention group
Group type: COMPARATOR
Intervention: Spontaneous pregnancies
Number of subjects: 630
Study 39703101 — intervention group
Group type: EXPERIMENTAL
Intervention: Group A (active tDCS-active rTMS)
Number of subjects: 105
Study 39703101 — intervention group
Group type: COMPARATOR
Intervention: Group B (sham tDCS-active rTMS)
Number of subjects: 105
Study 39703101 — intervention group
Group type: COMPARATOR
Intervention: Group C (active tDCS-sham rTMS)
Number of subjects: 105
Study 39703191 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcutaneous electrical nerve stimulation (TENS) of the greater occipital nerves (GON) for 8-12 weeks, stimulating for 30 minutes twice daily
Number of subjects: 36